Labetalol Hydrochloride Tablet, Film Coated
FDA Label NDC 70771-1165

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Labetalol Hydrochloride (NDC 70771-1165). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1163-3

Labetalol  hydrochloride tablets, 100 mg

Rx only

30 tablets

Labetalol  Hydrochloride Tablets (6c51333c Cf96 480d A340 F5680400cef4 01)

Labetalol Hydrochloride Tablets (6c51333c Cf96 480d A340 F5680400cef4 01)

NDC 70771-1164-3

Labetalol  hydrochloride tablets, 200 mg

Rx only

30 tablets

Labetalol  Hydrochloride Tablets (6c51333c Cf96 480d A340 F5680400cef4 02)

Labetalol Hydrochloride Tablets (6c51333c Cf96 480d A340 F5680400cef4 02)

NDC 70771-1165-3

Labetalol  hydrochloride tablets, 300 mg

Rx only

30 tablets

Labetalol  Hydrochloride Tablets (6c51333c Cf96 480d A340 F5680400cef4 03)

Labetalol Hydrochloride Tablets (6c51333c Cf96 480d A340 F5680400cef4 03)

* Please review the disclaimer below.